The ORBERA Intragastric Balloon, developed by Apollo Endosurgery, has received recognition from the American Society for Gastrointestinal Endoscopy.
The ASGE gave the ORBERA system a nod for meeting its Preservation and Incorporation of Valuable Endoscopic Innovations threshold standards for the treatment of obesity.
"ORBERA's recognition by ASGE as the only endoscopic treatment that currently meets their predetermined efficacy threshold underscores the importance of ORBERA as a proven and effective non-surgical solution to help patients and their doctors fight obesity before their disease requires more invasive treatments," said Todd Newton, CEO of Apollo Endosurgery.